The Global Virus Network: Challenging chikungunya

Akahata, 2010, A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection, Nat. Med., 16, 334, 10.1038/nm.2105 Albulescu, 2014, An in vitro assay to study chikungunya virus RNA synthesis and the mode of action of inhibitors, J. Gen. Virol., 95, 2683, 10.1099/vir.0.069690-0 Bourjot, 2014, Trigocherrierin A, a potent inhibitor of chikungunya virus replication, Molecules, 19, 3617, 10.3390/molecules19033617 Brandler, 2013, A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus, Vaccine, 31, 3718, 10.1016/j.vaccine.2013.05.086 Chang, 2014, Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial, Lancet, 384, 2046, 10.1016/S0140-6736(14)61185-5 Chattopadhyay, 2013, A chimeric vesiculo/alphavirus is an effective alphavirus vaccine, J. Virol., 87, 395, 10.1128/JVI.01860-12 Chen, 2015, Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection, J. Virol., 89, 581, 10.1128/JVI.02034-14 Couderc, 2008, A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease, PLoS Pathog., 4, e29, 10.1371/journal.ppat.0040029 Couderc, 2009, Prophylaxis and therapy for Chikungunya virus infection, J. Infect. Dis., 200, 516, 10.1086/600381 Edelman, 2000, Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218, Am. J. Trop. Med. Hyg., 62, 681, 10.4269/ajtmh.2000.62.681 Farnon, 2008, Severe disease manifestations associated with Acute chikungunya virus infection, Crit. Care Med., 36, 2682, 10.1097/CCM.0b013e3181843d94 Gammon, K., 2014. The cost of chikungunya to Jamaica. Jamaica Observer, 20 Oct. <www.jamaicaobserver.com/columns/The-cost-of-chikungunya-to-Jamaica_17772229> (accessed on April 7, 2015). Hallengard, 2014, Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice, J. Virol., 88, 2858, 10.1128/JVI.03453-13 Halstead, 2015, Reappearance of chikungunya, formerly called dengue, in the Americas, Emerg. Infect. Dis., 21, 557, 10.3201/eid2104.141723 Harrison, 1971, Production and evaluation of a formalin-killed Chikungunya vaccine, J. Immunol., 107, 643, 10.4049/jimmunol.107.3.643 Josseran, 2006, Chikungunya disease outbreak, Reunion Island, Emerg. Infect. Dis., 12, 1994, 10.3201/eid1212.060710 Kaur, 2013, Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression, Antimicrob. Agents Chemother., 57, 155, 10.1128/AAC.01467-12 Khan, 2010, Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells, J. Med. Virol., 82, 817, 10.1002/jmv.21663 Labadie, 2010, Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages, J. Clin. Invest., 120, 894, 10.1172/JCI40104 Lemant, 2008, Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005–2006, Crit. Care Med., 36, 2536, 10.1097/CCM.0b013e318183f2d2 Levitt, 1986, Development of an attenuated strain of chikungunya virus for use in vaccine production, Vaccine, 4, 157, 10.1016/0264-410X(86)90003-4 Mallilankaraman, 2011, A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates, PLoS Negl. Trop. Dis., 5, e928, 10.1371/journal.pntd.0000928 Mavalankar, 2008, Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India, Emerg. Infect. Dis., 14, 412, 10.3201/eid1403.070720 Morrison, 2014, Reemergence of chikungunya virus, J. Virol., 88, 11644, 10.1128/JVI.01432-14 Plante, 2011, Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism, PLoS Pathog., 7, e1002142, 10.1371/journal.ppat.1002142 Pohjala, 2011, Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays, PLoS One, 6, e28923, 10.1371/journal.pone.0028923 Ramsauer, 2015, Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial, Lancet Infect. Dis., 15, 519, 10.1016/S1473-3099(15)70043-5 Roy, 2014, Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose, J. Infect. Dis., 209, 1891, 10.1093/infdis/jiu014 Rulli, 2011, Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis, J. Infect. Dis., 204, 1026, 10.1093/infdis/jir470 Schilte, 2010, Type I IFN controls chikungunya virus via its action on non-hematopoietic cells, J. Exp. Med., 207, 429, 10.1084/jem.20090851 Schilte, 2013, Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study, PLoS Negl. Trop. Dis., 7, e2137, 10.1371/journal.pntd.0002137 Soumahoro, 2011, The chikungunya epidemic on La Réunion Island in 2005–2006: a cost-of-illness study, PLoS Negl. Trop. Dis., 5, e1197, 10.1371/journal.pntd.0001197 Staikowsky, 2009, Prospective study of Chikungunya virus acute infection in the Island of La Reunion during the 2005–2006 outbreak, PLoS One, 4, e7603, 10.1371/journal.pone.0007603 Thiberville, 2013, Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean, PLoS Negl. Trop. Dis., 7, e2004, 10.1371/journal.pntd.0002004 Thiberville, 2013, Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy, Antiviral Res., 99, 345, 10.1016/j.antiviral.2013.06.009 Tretyakova, 2014, DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice, J. Infect. Dis., 209, 1882, 10.1093/infdis/jiu114 Wang, 2008, Chimeric alphavirus vaccine candidates for chikungunya, Vaccine, 26, 5030, 10.1016/j.vaccine.2008.07.054 Weaver, 2015, Chikungunya: evolutionary history and recent epidemic spread, Antiviral Res., 120, 32, 10.1016/j.antiviral.2015.04.016 Zakaib, G.D. Virologists form Global Virus Response Network. Nature News Blog, 3 March 201l (accessed March 23, 2015).